Metavention, Inc. Company Profile
News Articles
Metavention obtains $65M in funding round, names new CEO
A round of Series C financing brought in $65 million for Eden Prairie, Minn.-based Metavention, which intends to use the mone -More-
Series C lands $65mm for Metavention
Metavention Inc. (diabetes device maker) raised $65mm in its Series C financing led by New Enterprise Associates, which was joined by first-time backers Sanderling Ventures, RK Mellon and Horowitz Gro...
Metavention, Inc., Closes $65 Million in Series C Funding, Appoints New Chief Executive Officer
Capital to enable Phase 2 trials for Metabolic Neuromodulation Therapy, an important new treatment for Type 2 diabetes. Metavention, Inc., today announced the completion of $6...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
More Information about "Metavention, Inc." on BioPortfolio
We have published hundreds of Metavention, Inc. news stories on BioPortfolio along with dozens of Metavention, Inc. Clinical Trials and PubMed Articles about Metavention, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Metavention, Inc. Companies in our database. You can also find out about relevant Metavention, Inc. Drugs and Medications on this site too.
